| abstract |
The invention relates to novel substituted arylsulfonylaminoguanidinoazines of the formula in which R 1 is each optionally substituted aryl, aralkyl or heteroaryl, R 2 is hydroxyl, amino or in each case optionally substituted alkoxy or alkylamino, R 3 is hydrogen, halogen, hydroxyl, alkyl, haloalkyl, Alkoxyalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkylamino or dialkylamino, X is nitrogen or a CH grouping, Y is nitrogen or a CR4 grouping, wherein R4 is hydrogen, halogen, cyano, alkyl, formyl, Alkylcarbonyl or alkoxycarbonyl, and Z is nitrogen or a CR 5 grouping in which R 5 represents hydrogen, halogen, hydroxyl, alkyl, alkoxy, alkylthio, alkylamino or dialkylamino, |